MolNFT v1 · #167733 · protein
Crystal structure of human galectin-7 in complex with 4-O-beta-D- galactopyranosyl-D-glucose
6VTO: “Crystal structure of human galectin-7 in complex with 4-O-beta-D- galactopyranosyl-D-glucose”. X-ray diffraction, 1 ligand (LBL), 2 pockets (best druggability 0.28). MolNFT v1 #167733 on GenesisL1: 3D structure, binding sites and…
- PDB
- 6VTO
- Type
- protein
- Length
- 268 residues
- Chains
- 2
- Method
- x-ray diffraction
- Collection
- MolNFT v1 / PDB
- Contract
- 0xDE3723766Bc32dcACD03C17BaA400A7B36837Eba
- Owner
- 0x3396CDB397284571d12822B4ae1189a8E22AAAAA
- Molecule
- Galectin-7
- UniProt
- P47929
- Ligands
- LBL
- Pockets
- 2 · best druggability 0.28
Structure
x-ray diffraction · 1 distinct chain · 2% helix, 54% strand (DSSP).
| Chain | Molecule | Type | Residues | Secondary structure | UniProt |
|---|---|---|---|---|---|
| A, B | Galectin-7 | protein | 134 | 2% helix, 54% strand | P47929 |
Ligands and binding sites
- LBL · (2~{R},3~{R},4~{R},5~{R})-4-[(2~{S},3~{R},4~{S},5~{R}, 6~{R})-6-(hydroxymethyl)-3,4,5-tris(oxidanyl)oxan-2-yl]oxy-2,3,5, 6-tetrakis(oxidanyl)hexanal · ligand · 2 copies · chains A, B
Binding sites are the residues within 4.5 Å of a ligand's heavy atoms.
Pockets
2 pockets found on a 1 Å grid, 0 with a druggability of 0.5 or more.
| Volume (ų) | Druggability | Buriedness | Lining residues | Inside | |
|---|---|---|---|---|---|
| 1 | 63 | 0.28 | 0.74 | 13 | empty |
| 2 | 56 | 0.26 | 0.73 | 15 | empty |
Interfaces
1 interface between chains.
- A–B · 831 Ų buried · 18 hydrogen bonds · protein-protein
Compared structures
Analyse
- Open in the research workbench: secondary structure, accessibility, pockets, interfaces, conservation, variants, modifications, peptides and crosslinks on the 3D structure
- Every structure of UniProt P47929
- Elsewhere: RCSB PDB 6VTO · PDBe 6VTO · UniProt P47929
GL1X is a live explorer of the GenesisL1 blockchain. Turn on JavaScript for search, charts and interactive views.